Related references
Note: Only part of the references are listed.DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
Lukas Perkhofer et al.
GUT (2021)
Genomic destabilization and its associated mutagenesis increase with senescence-associated phenotype expression
Ken-ichi Yoshioka et al.
CANCER SCIENCE (2021)
Long non-coding RNA C5orf64 is a potential indicator for tumor microenvironment and mutation pattern remodeling in lung adenocarcinoma
Zhaofei Pang et al.
GENOMICS (2021)
Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance
Adalgisa Condoluci et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma
Jie Sheng et al.
CANCER LETTERS (2021)
Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer
Siqi Bao et al.
BRIEFINGS IN BIOINFORMATICS (2020)
An independently validated survival nomogram for lower-grade glioma
Haley Gittleman et al.
NEURO-ONCOLOGY (2020)
Mechanism of long noncoding RNAs as transcriptional regulators in cancer
Yan Huang et al.
RNA BIOLOGY (2020)
A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy
Wanzun Lin et al.
AGING-US (2020)
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature
Victor M. Lu et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1
Yuhui Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard et al.
NATURE MEDICINE (2020)
Identification and validation of a six-lncRNA prognostic signature with its ceRNA networks and candidate drugs in lower-grade gliomas
Jia-zhe Lin et al.
GENOMICS (2020)
A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
Chaoqi Zhang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
H19 Knockdown Suppresses Proliferation and Induces Apoptosis by Regulating miR-130a-3p/SATB1 in Breast Cancer Cells
Guobin Zhong et al.
ONCOTARGETS AND THERAPY (2020)
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations
Hideyuki Arita et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older Patients
Pamela S. Jones et al.
NEUROSURGERY (2019)
Neuro-oncology: Implications of the molecular era
Michael W. Ruff et al.
NEUROLOGY (2019)
Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma
Yunqiu Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response
Felipe J. Nunez et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas
Tiefeng Cao et al.
ONCOGENE (2019)
Noncoding RNA: Aging well with Norad
Filipa Carvalhal Marques et al.
ELIFE (2019)
PUMILIO hyperactivity drives premature aging of Norad-deficient mice
Florian Kopp et al.
ELIFE (2019)
Genome-wide identification of lncRNAs as novel prognosis biomarkers of glioma
Lianhao Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Total copy number variation as a prognostic factor in adult astrocytoma subtypes
Kanish Mirchia et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Survival analysis of immune-related lncRNA in low-grade glioma
Xiaozhi Li et al.
BMC CANCER (2019)
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors
Ron D. Jachimowicz et al.
CELL (2019)
Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics
C. Izquierdo et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/beta-Catenin pathway
Linwei Jia et al.
ONCOTARGETS AND THERAPY (2018)
Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients
Giorgia Acquaviva et al.
SCIENTIFIC REPORTS (2018)
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability
Mathias Munschauer et al.
NATURE (2018)
PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma
Feng Dong et al.
NATURE COMMUNICATIONS (2018)
Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours
Ze Rui Wu et al.
NATURE COMMUNICATIONS (2018)
Noncoding RNA Ginir functions as an oncogene by associating with centrosomal proteins
Suchismita Panda et al.
PLOS BIOLOGY (2018)
GenomeVIP: a cloud platform for genomic variant discovery and interpretation
R. Jay Mashl et al.
GENOME RESEARCH (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins
Sungyul Lee et al.
CELL (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy
Pengfei Jiang et al.
ONCOTARGETS AND THERAPY (2016)
MiR675-5p Acts on HIF-1 alpha to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma
Alessia Lo Dico et al.
THERANOSTICS (2016)
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma
Shih-Yi Lin et al.
SCIENTIFIC REPORTS (2016)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach
Hugues Duffau et al.
NEURO-ONCOLOGY (2015)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
C. Houillier et al.
NEUROLOGY (2010)
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Lonneke A. M. Gravendeel et al.
CANCER RESEARCH (2009)
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis
Dalia Barsyte-Lovejoy et al.
CANCER RESEARCH (2006)
Share Paper
